In this study, we explored how miR-139-5p regulates depression and exerts its antidepressant-like effect via activating the BDNF-TrkB pathway and suggested the BDNF-TrkB pathway could be a new depression drug target (Fig. graphical abstract). The gene discussed is BDNF; the disease is depressive symptom measurement.